Alkermes to Present at Two Upcoming Investor Conferences

Business Wire


Alkermes plc (ALKS) announced today that it will webcast a live fireside chat, featuring Richard Pops, at the 16th Annual BIO CEO & Investor Conference on Monday, Feb. 10, 2014, at 8:00 a.m. EST (1:00 p.m. GMT) from the Waldorf Astoria Hotel in New York City. The fireside chat will be moderated by David Gluckman, M.D., Managing Director, Global Co-Head of Healthcare, Lazard Ltd. In addition, Alkermes’ corporate presentation will be webcast live at the Leerink Swann Global Healthcare Conference 2014 on Wednesday, Feb. 12, 2014, at 8:50 a.m. EST (1:50 p.m. GMT), also from the Waldorf Astoria Hotel in New York City. These presentations may be accessed under the Investors tab on and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and manufacturing facilities in Gainesville, Georgia and Wilmington, Ohio. For more information, please visit Alkermes’ website at

Alkermes plc
Eva Stroynowski, +1-781-609-6823
Corporate Communications

View Comments (0)